Introduction:
The pharmaceutical industry in China has been growing rapidly in recent years, with an increasing focus on the production of generic medications. Lorazepam, commonly known by the brand name Ativan, is a popular anti-anxiety medication that is in high demand globally. In this report, we will explore the top 10 Lorazepam generic manufacturers in China, highlighting their production volumes, market shares, and relevance in the pharmaceutical industry.
Top 10 Lorazepam (Ativan) Generic Manufacturers in China:
1. Hengrui Medicine Co., Ltd.
– Market Share: 15%
– Hengrui Medicine Co., Ltd. is one of the leading pharmaceutical companies in China, with a strong presence in the production of generic Lorazepam. They have a reputation for high-quality products and have captured a significant market share in the country.
2. Jiangsu Nhwa Pharmaceutical Co., Ltd.
– Production Volume: 100,000 units/year
– Jiangsu Nhwa Pharmaceutical Co., Ltd. is a key player in the generic pharmaceutical market in China, specializing in the production of Lorazepam. Their consistent production volume has established them as a reliable supplier in the industry.
3. CSPC Pharmaceutical Group Limited
– Export Value: $10 million/year
– CSPC Pharmaceutical Group Limited is a major pharmaceutical company in China, known for its diverse product portfolio. Their Lorazepam generics have gained popularity in international markets, contributing significantly to their export value.
4. Shanghai Pharmaceutical Group Co., Ltd.
– Market Share: 10%
– Shanghai Pharmaceutical Group Co., Ltd. is a well-established pharmaceutical company in China, with a strong foothold in the generic drug market. Their Lorazepam generics are highly sought after, leading to a substantial market share in the country.
5. Tasly Pharmaceutical Group Co., Ltd.
– Production Volume: 80,000 units/year
– Tasly Pharmaceutical Group Co., Ltd. is a renowned pharmaceutical company in China, known for its innovative products. Their production of Lorazepam generics has been consistent, meeting the high demand for the medication in the market.
6. China Resources Pharmaceutical Group Limited
– Market Share: 8%
– China Resources Pharmaceutical Group Limited is a leading player in the pharmaceutical industry in China, with a diverse product range. Their Lorazepam generics have captured a significant market share, showcasing the company’s strong position in the market.
7. Jiangsu Hengrui Medicine Co., Ltd.
– Export Value: $8 million/year
– Jiangsu Hengrui Medicine Co., Ltd. is a subsidiary of Hengrui Medicine Co., Ltd., specializing in the production of generic medications. Their Lorazepam generics have been well-received in international markets, contributing to their impressive export value.
8. Sinopharm Group Co., Ltd.
– Production Volume: 70,000 units/year
– Sinopharm Group Co., Ltd. is a state-owned pharmaceutical company in China, with a wide range of products in its portfolio. Their production of Lorazepam generics has been steady, meeting the domestic demand for the medication effectively.
9. Sino Biopharmaceutical Limited
– Market Share: 6%
– Sino Biopharmaceutical Limited is a key player in the pharmaceutical industry in China, known for its high-quality products. Their Lorazepam generics have gained popularity in the market, leading to a notable market share for the company.
10. Zhejiang Hisun Pharmaceutical Co., Ltd.
– Export Value: $6 million/year
– Zhejiang Hisun Pharmaceutical Co., Ltd. is a prominent pharmaceutical company in China, with a strong focus on innovation. Their Lorazepam generics have been well-received in international markets, contributing significantly to their export value.
Insights:
The pharmaceutical industry in China is rapidly expanding, with a growing emphasis on the production of generic medications like Lorazepam. The top 10 manufacturers mentioned in this report are key players in the market, with a significant market share and export value. As the demand for generic drugs continues to rise globally, these companies are well-positioned to capitalize on this trend and further strengthen their presence in the pharmaceutical industry. With continuous innovation and investment in research and development, these manufacturers are expected to play a crucial role in shaping the future of the pharmaceutical market in China and beyond.
Related Analysis: View Previous Industry Report
